{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:01:35Z","timestamp":1791475295300,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K23DK116935"],"award-info":[{"award-number":["K23DK116935"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1038\/s41591-025-03556-3","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T10:03:58Z","timestamp":1741341838000},"page":"1653-1660","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Anti-obesity medication for weight loss in early nonresponders to behavioral treatment: a randomized controlled trial"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3587-4130","authenticated-orcid":false,"given":"Jena S.","family":"Tronieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Ghanbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4535-8108","authenticated-orcid":false,"given":"Jonathan","family":"Chevinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8505-6366","authenticated-orcid":false,"given":"Erica M.","family":"LaFata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7699-0184","authenticated-orcid":false,"given":"Alyssa M.","family":"Minnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9756-7510","authenticated-orcid":false,"given":"Simran","family":"Rajpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7529-6147","authenticated-orcid":false,"given":"Seamus Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylie","family":"Burcaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert I.","family":"Berkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0438-4609","authenticated-orcid":false,"given":"Thomas A.","family":"Wadden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"key":"3556_CR1","doi-asserted-by":"publisher","first-page":"g6608","DOI":"10.1136\/bmj.g6608","volume":"349","author":"H Stegenga","year":"2014","unstructured":"Stegenga, H. et al. Identification, assessment, and management of overweight and obesity: summary of updated NICE guidance. BMJ 349, g6608 (2014).","journal-title":"BMJ"},{"key":"3556_CR2","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1016\/j.jacc.2013.11.004","volume":"63","author":"MD Jensen","year":"2014","unstructured":"Jensen, M. D. et al. 2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J. Am. Coll. Cardiol. 63, 2985\u20133023 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"3556_CR3","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.2337\/dc10-2415","volume":"34","author":"RR Wing","year":"2011","unstructured":"Wing, R. R. et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care 34, 1481\u20131486 (2011).","journal-title":"Diabetes Care"},{"key":"3556_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/ijo.2009.213","volume":"34","author":"JG Christian","year":"2010","unstructured":"Christian, J. G., Tsai, A. G. & Bessesen, D. H. Interpreting weight losses from lifestyle modification trials: using categorical data. Int. J. Obes. 34, 207\u2013209 (2010).","journal-title":"Int. J. Obes."},{"key":"3556_CR5","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1002\/oby.20777","volume":"22","author":"JL Unick","year":"2014","unstructured":"Unick, J. L. et al. Evaluation of early weight loss thresholds for identifying nonresponders to an intensive lifestyle intervention. Obesity 22, 1608\u20131616 (2014).","journal-title":"Obesity"},{"key":"3556_CR6","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.brat.2009.05.004","volume":"47","author":"AN Fabricatore","year":"2009","unstructured":"Fabricatore, A. N. et al. Predictors of attrition and weight loss success: results from a randomized controlled trial. Behav. Res. Ther. 47, 685\u2013691 (2009).","journal-title":"Behav. Res. Ther."},{"key":"3556_CR7","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jpsychores.2014.03.004","volume":"76","author":"ME Waring","year":"2014","unstructured":"Waring, M. E. et al. Early-treatment weight loss predicts 6-month weight loss in women with obesity and depression: implications for stepped care. J. Psychosom. Res. 76, 394\u2013399 (2014).","journal-title":"J. Psychosom. Res."},{"key":"3556_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1475-2891-13-13","volume":"13","author":"O Colombo","year":"2014","unstructured":"Colombo, O. et al. Is drop-out from obesity treatment a predictable and preventable event?. Nutr. J. 13, 13 (2014).","journal-title":"Nutr. J."},{"key":"3556_CR9","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s10865-015-9691-9","volume":"39","author":"JL Unick","year":"2016","unstructured":"Unick, J. L. et al. A preliminary investigation into whether early intervention can improve weight loss among those initially non-responsive to an internet-based behavioral program. J. Behav. Med. 39, 254\u2013261 (2016).","journal-title":"J. Behav. Med."},{"key":"3556_CR10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s10865-009-9221-8","volume":"32","author":"RA Carels","year":"2009","unstructured":"Carels, R. A. et al. Successful weight loss with self-help: a stepped-care approach. J. Behav. Med. 32, 503\u2013509 (2009).","journal-title":"J. Behav. Med."},{"key":"3556_CR11","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1001\/jama.2012.6866","volume":"307","author":"JM Jakicic","year":"2012","unstructured":"Jakicic, J. M. et al. Effect of a stepped-care intervention approach on weight loss in adults: a randomized clinical trial. JAMA 307, 2617\u20132626 (2012).","journal-title":"JAMA"},{"key":"3556_CR12","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1093\/abm\/kay036","volume":"53","author":"JS Tronieri","year":"2018","unstructured":"Tronieri, J. S. et al. Early weight loss in behavioral treatment predicts later rate of weight loss and response to pharmacotherapy. Ann. Behav. Med. 53, 290\u2013295 (2018).","journal-title":"Ann. Behav. Med."},{"key":"3556_CR13","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1093\/ajcn\/69.6.1108","volume":"69","author":"JO Hill","year":"1999","unstructured":"Hill, J. O. et al. Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study. Am. J. Clin. Nutr. 69, 1108\u20131116 (1999).","journal-title":"Am. J. Clin. Nutr."},{"key":"3556_CR14","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/ijo.2013.120","volume":"37","author":"TA Wadden","year":"2013","unstructured":"Wadden, T. A. et al. Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study. Int. J. Obes. 37, 1443\u20131451 (2013).","journal-title":"Int. J. Obes."},{"key":"3556_CR15","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1038\/s41591-023-02597-w","volume":"29","author":"TA Wadden","year":"2023","unstructured":"Wadden, T. A. et al. Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial. Nat. Med. 29, 2909\u20132918 (2023).","journal-title":"Nat. Med."},{"key":"3556_CR16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/oby.22726","volume":"28","author":"TA Wadden","year":"2020","unstructured":"Wadden, T. A. et al. Liraglutide 3.0 mg and intensive behavioral therapy (IBT) for obesity in primary care: the SCALE IBT randomized controlled trial. Obesity 28, 529\u2013536 (2020).","journal-title":"Obesity"},{"key":"3556_CR17","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/oby.2010.147","volume":"19","author":"TA Wadden","year":"2011","unstructured":"Wadden, T. A. et al. Weight loss with naltrexone SR\/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial. Obesity 19, 110\u2013120 (2011).","journal-title":"Obesity"},{"key":"3556_CR18","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1001\/jama.2021.1831","volume":"325","author":"TA Wadden","year":"2021","unstructured":"Wadden, T. A. et al. Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial. JAMA 325, 1403\u20131413 (2021).","journal-title":"JAMA"},{"key":"3556_CR19","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1111\/j.1463-1326.2010.01242.x","volume":"12","author":"JG Kang","year":"2010","unstructured":"Kang, J. G., Park, C., Kang, J. H., Park, Y. W. & Park, S. W. Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse\u2010controlled release for obesity. Diabetes Obes. Metab. 12, 876\u2013882 (2010).","journal-title":"Diabetes Obes. Metab."},{"key":"3556_CR20","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1002\/oby.20584","volume":"21","author":"LJ Aronne","year":"2013","unstructured":"Aronne, L. J. et al. Evaluation of phentermine and topiramate versus phentermine\/topiramate extended-release in obese adults. Obesity 21, 2163\u20132171 (2013).","journal-title":"Obesity"},{"key":"3556_CR21","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1038\/oby.2011.94","volume":"19","author":"EJ Hendricks","year":"2011","unstructured":"Hendricks, E. J., Greenway, F. L., Westman, E. C. & Gupta, A. K. Blood pressure and heart rate effects, weight loss and maintenance during long-term phentermine pharmacotherapy for obesity. Obesity 19, 2351\u20132360 (2011).","journal-title":"Obesity"},{"key":"3556_CR22","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/oby.22430","volume":"27","author":"KH Lewis","year":"2019","unstructured":"Lewis, K. H. et al. Safety and effectiveness of longer\u2010term phentermine use: clinical outcomes from an electronic health record cohort. Obesity 27, 591\u2013602 (2019).","journal-title":"Obesity"},{"key":"3556_CR23","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1136\/bmj.1.5588.352","volume":"1","author":"JF Munro","year":"1968","unstructured":"Munro, J. F., MacCuish, A. C., Wilson, E. M. & Duncan, J. L. Comparison of continuous and intermittent anorectic therapy in obesity. BMJ 1, 352\u2013354 (1968).","journal-title":"BMJ"},{"key":"3556_CR24","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.2337\/diacare.25.12.2165","volume":"25","author":"Diabetes Prevention Program (DPP) Research Group.","year":"2002","unstructured":"Diabetes Prevention Program (DPP) Research Group. The Diabetes Prevention Program (DPP) description of lifestyle intervention. Diabetes Care 25, 2165\u20132171 (2002).","journal-title":"Diabetes Care"},{"key":"3556_CR25","doi-asserted-by":"crossref","unstructured":"Look AHEAD Research Group, et al. The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity 14, 737\u2013752 (2006).","DOI":"10.1038\/oby.2006.84"},{"key":"3556_CR26","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2206038","volume":"387","author":"AM Jastreboff","year":"2022","unstructured":"Jastreboff, A. M. et al. Tirzepatide once weekly for the treatment of obesity. N. Engl. J. Med. 387, 205\u2013216 (2022).","journal-title":"N. Engl. J. Med."},{"key":"3556_CR27","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","volume":"384","author":"JP Wilding","year":"2021","unstructured":"Wilding, J. P. et al. Once-weekly semaglutide in adults with overweight or obesity. N. Engl. J. Med. 384, 989\u20131002 (2021).","journal-title":"N. Engl. J. Med."},{"key":"3556_CR28","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s13679-023-00534-z","volume":"12","author":"TA Wadden","year":"2023","unstructured":"Wadden, T. A. et al. The role of lifestyle modification with second-generation anti-obesity medications: comparisons, questions, and clinical opportunities. Curr. Obes. Rep. 12, 453\u2013473 (2023).","journal-title":"Curr. Obes. Rep."},{"key":"3556_CR29","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1002\/oby.22594","volume":"27","author":"TA Wadden","year":"2019","unstructured":"Wadden, T. A., Tsai, A. G. & Tronieri, J. S. A protocol to deliver intensive behavioral therapy (IBT) for obesity in primary care settings: the MODEL\u2010IBT program. Obesity 27, 1562\u20131566 (2019).","journal-title":"Obesity"},{"key":"3556_CR30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/oby.2001.13","volume":"9","author":"RL Kolotkin","year":"2001","unstructured":"Kolotkin, R. L., Crosby, R. D., Kosloski, K. D. & Williams, G. R. Development of a brief measure to assess quality of life in obesity. Obes. Res. 9, 102\u2013111 (2001).","journal-title":"Obes. Res."},{"key":"3556_CR31","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke, K., Spitzer, R. L. & Williams, J. B. The PHQ\u20109: validity of a brief depression severity measure. J. Gen. Intern. Med. 16, 606\u2013613 (2001).","journal-title":"J. Gen. Intern. Med."},{"key":"3556_CR32","doi-asserted-by":"publisher","unstructured":"Stunkard, A. J. & Messick, S. Eating inventory. APA PsychTests https:\/\/doi.org\/10.1037\/t15085-000 (1988).","DOI":"10.1037\/t15085-000"},{"key":"3556_CR33","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1093\/oxfordjournals.aje.a117736","volume":"142","author":"RS Paffenbarger Jr.","year":"1978","unstructured":"Paffenbarger, R. S. Jr., Wing, A. L. & Hyde, R. T. Physical activity as an index of heart attack risk in college alumni. Am. J. Epidemiol. 142, 889\u2013903 (1978).","journal-title":"Am. J. Epidemiol."},{"key":"3556_CR34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/01621459.1993.10594302","volume":"88","author":"RJ Little","year":"1993","unstructured":"Little, R. J. Pattern-mixture models for multivariate incomplete data. J. Am. Stat. Assoc. 88, 125\u2013134 (1993).","journal-title":"J. Am. Stat. Assoc."},{"key":"3556_CR35","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s11121-007-0070-9","volume":"8","author":"JW Graham","year":"2007","unstructured":"Graham, J. W., Olchowski, A. E. & Gilreath, T. D. How many imputations are really needed? Some practical clarifications of multiple imputation theory. Prev. Sci. 8, 206\u2013213 (2007).","journal-title":"Prev. Sci."},{"key":"3556_CR36","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1080\/01621459.1996.10476908","volume":"91","author":"DB Rubin","year":"1996","unstructured":"Rubin, D. B. Multiple imputation after 18+ years. J. Am. Stat. Assoc. 91, 473\u2013489 (1996).","journal-title":"J. Am. Stat. Assoc."},{"key":"3556_CR37","unstructured":"Robitzsch, A. & Grund, S. miceadds: some additional multiple imputation functions, especially for \u2018mice\u2019. R version 3.17-44. CRAN cran.r-project.org\/web\/packages\/miceadds\/index.html (2024)."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03556-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03556-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03556-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T14:57:34Z","timestamp":1747753054000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03556-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["3556"],"URL":"https:\/\/doi.org\/10.1038\/s41591-025-03556-3","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]},"assertion":[{"value":"25 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.S.T. reports an investigator-initiated grant, on behalf of the University of Pennsylvania, from Novo Nordisk. T.A.W. reports serving on advisory boards for Novo Nordisk and Weight Watchers, and receiving grants, on behalf of the University of Pennsylvania, from Eli Lilly, Epitomee Medical and Novo Nordisk. R.I.B. served as a consultant to Eisai Pharmaceutical during the conduct of this trial. E.G., J.C., E.M.L., A.M.M., S.R., S.Y.W. and K.B. report no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}